AtriCure Pretax Profit Margin from 2010 to 2024

ATRC Stock  USD 23.17  0.46  2.03%   
AtriCure's Pretax Profit Margin is increasing over the years with slightly volatile fluctuation. Pretax Profit Margin is expected to dwindle to -0.08. During the period from 2010 to 2024 AtriCure Pretax Profit Margin annual values regression line had geometric mean of  0.15 and mean square error of  0.01. View All Fundamentals
 
Pretax Profit Margin  
First Reported
2010-12-31
Previous Quarter
(0.07)
Current Value
(0.08)
Quarterly Volatility
0.12235783
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check AtriCure financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AtriCure main balance sheet or income statement drivers, such as Interest Expense of 7.3 M, Total Revenue of 419.2 M or Gross Profit of 312.3 M, as well as many exotic indicators such as Price To Sales Ratio of 3.93, Dividend Yield of 0.0081 or PTB Ratio of 3.76. AtriCure financial statements analysis is a perfect complement when working with AtriCure Valuation or Volatility modules.
  
This module can also supplement AtriCure's financial leverage analysis and stock options assessment as well as various AtriCure Technical models . Check out the analysis of AtriCure Correlation against competitors.
For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.

Latest AtriCure's Pretax Profit Margin Growth Pattern

Below is the plot of the Pretax Profit Margin of AtriCure over the last few years. It is AtriCure's Pretax Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AtriCure's overall financial position and show how it may be relating to other accounts over time.
Pretax Profit Margin10 Years Trend
Slightly volatile
   Pretax Profit Margin   
       Timeline  

AtriCure Pretax Profit Margin Regression Statistics

Arithmetic Mean(0.14)
Geometric Mean0.15
Coefficient Of Variation(88.90)
Mean Deviation0.07
Median(0.14)
Standard Deviation0.12
Sample Variance0.01
Range0.5919
R-Value0.45
Mean Square Error0.01
R-Squared0.21
Significance0.09
Slope0.01
Total Sum of Squares0.21

AtriCure Pretax Profit Margin History

2024 -0.0785
2023 -0.0748
2021 0.18
2020 -0.23
2018 -0.1
2015 -0.21
2014 -0.15

About AtriCure Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include AtriCure income statement, its balance sheet, and the statement of cash flows. AtriCure investors use historical funamental indicators, such as AtriCure's Pretax Profit Margin, to determine how well the company is positioned to perform in the future. Although AtriCure investors may use each financial statement separately, they are all related. The changes in AtriCure's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on AtriCure's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on AtriCure Financial Statements. Understanding these patterns can help to make the right decision on long term investment in AtriCure. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Pretax Profit Margin(0.07)(0.08)

AtriCure Investors Sentiment

The influence of AtriCure's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in AtriCure. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to AtriCure's public news can be used to forecast risks associated with an investment in AtriCure. The trend in average sentiment can be used to explain how an investor holding AtriCure can time the market purely based on public headlines and social activities around AtriCure. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
AtriCure's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for AtriCure's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average AtriCure's news discussions. The higher the estimated score, the more favorable is the investor's outlook on AtriCure.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards AtriCure in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, AtriCure's short interest history, or implied volatility extrapolated from AtriCure options trading.

Pair Trading with AtriCure

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AtriCure position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AtriCure will appreciate offsetting losses from the drop in the long position's value.

Moving together with AtriCure Stock

  0.84NRC National Research CorpPairCorr

Moving against AtriCure Stock

  0.78DSGN Design Therapeutics Financial Report 14th of May 2024 PairCorr
  0.75NXL Nexalin TechnologyPairCorr
  0.67IRIX IRIDEX Financial Report 9th of May 2024 PairCorr
  0.41AGTI Agiliti Financial Report 14th of May 2024 PairCorr
The ability to find closely correlated positions to AtriCure could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AtriCure when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AtriCure - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AtriCure to buy it.
The correlation of AtriCure is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AtriCure moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AtriCure moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AtriCure can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether AtriCure offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AtriCure's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Atricure Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Atricure Stock:
Check out the analysis of AtriCure Correlation against competitors.
For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.
You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Complementary Tools for AtriCure Stock analysis

When running AtriCure's price analysis, check to measure AtriCure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AtriCure is operating at the current time. Most of AtriCure's value examination focuses on studying past and present price action to predict the probability of AtriCure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AtriCure's price. Additionally, you may evaluate how the addition of AtriCure to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Is AtriCure's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AtriCure. If investors know AtriCure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AtriCure listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.66)
Revenue Per Share
8.621
Quarterly Revenue Growth
0.21
Return On Assets
(0.03)
Return On Equity
(0.07)
The market value of AtriCure is measured differently than its book value, which is the value of AtriCure that is recorded on the company's balance sheet. Investors also form their own opinion of AtriCure's value that differs from its market value or its book value, called intrinsic value, which is AtriCure's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AtriCure's market value can be influenced by many factors that don't directly affect AtriCure's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AtriCure's value and its price as these two are different measures arrived at by different means. Investors typically determine if AtriCure is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AtriCure's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.